FR2955393B1 - METHOD FOR ASSESSING THE EFFECTIVENESS OF VECTOR CONTROL STRATEGIES IN THE CONTROL OF MALARIA AND ARBOVIROSIS - Google Patents

METHOD FOR ASSESSING THE EFFECTIVENESS OF VECTOR CONTROL STRATEGIES IN THE CONTROL OF MALARIA AND ARBOVIROSIS

Info

Publication number
FR2955393B1
FR2955393B1 FR1000172A FR1000172A FR2955393B1 FR 2955393 B1 FR2955393 B1 FR 2955393B1 FR 1000172 A FR1000172 A FR 1000172A FR 1000172 A FR1000172 A FR 1000172A FR 2955393 B1 FR2955393 B1 FR 2955393B1
Authority
FR
France
Prior art keywords
control
arbovirosis
malaria
assessing
effectiveness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1000172A
Other languages
French (fr)
Other versions
FR2955393A1 (en
Inventor
Franck Jacques Louis-Marie Remoue
Anne Claire Poinsignon
Sylvie Caroline Cornelie
Papa Makhtar Drame
Souleymane Doucoure
Francois Jacques Andre Mouchet
Marie Aude Bernadette Rossignol
Vincent Bernard Camille Corbel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche pour le Developpement IRD
Original Assignee
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Recherche pour le Developpement IRD filed Critical Institut de Recherche pour le Developpement IRD
Priority to FR1000172A priority Critical patent/FR2955393B1/en
Priority to PCT/IB2011/050210 priority patent/WO2011086535A1/en
Priority to EP11705033A priority patent/EP2526418A1/en
Priority to AP2012006415A priority patent/AP2012006415A0/en
Publication of FR2955393A1 publication Critical patent/FR2955393A1/en
Application granted granted Critical
Publication of FR2955393B1 publication Critical patent/FR2955393B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43552—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR1000172A 2010-01-18 2010-01-18 METHOD FOR ASSESSING THE EFFECTIVENESS OF VECTOR CONTROL STRATEGIES IN THE CONTROL OF MALARIA AND ARBOVIROSIS Active FR2955393B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1000172A FR2955393B1 (en) 2010-01-18 2010-01-18 METHOD FOR ASSESSING THE EFFECTIVENESS OF VECTOR CONTROL STRATEGIES IN THE CONTROL OF MALARIA AND ARBOVIROSIS
PCT/IB2011/050210 WO2011086535A1 (en) 2010-01-18 2011-01-18 Method for assessing the effectiveness of anti-vector control strategies in the control of malaria and arbovirosis
EP11705033A EP2526418A1 (en) 2010-01-18 2011-01-18 Method for assessing the effectiveness of anti-vector control strategies in the control of malaria and arbovirosis
AP2012006415A AP2012006415A0 (en) 2010-01-18 2011-01-18 Method for assessing the effectiveness of anti-vector control strategies in the control of malaria and arbovirosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1000172A FR2955393B1 (en) 2010-01-18 2010-01-18 METHOD FOR ASSESSING THE EFFECTIVENESS OF VECTOR CONTROL STRATEGIES IN THE CONTROL OF MALARIA AND ARBOVIROSIS

Publications (2)

Publication Number Publication Date
FR2955393A1 FR2955393A1 (en) 2011-07-22
FR2955393B1 true FR2955393B1 (en) 2015-12-11

Family

ID=42315484

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1000172A Active FR2955393B1 (en) 2010-01-18 2010-01-18 METHOD FOR ASSESSING THE EFFECTIVENESS OF VECTOR CONTROL STRATEGIES IN THE CONTROL OF MALARIA AND ARBOVIROSIS

Country Status (4)

Country Link
EP (1) EP2526418A1 (en)
AP (1) AP2012006415A0 (en)
FR (1) FR2955393B1 (en)
WO (1) WO2011086535A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0717864D0 (en) * 2007-09-13 2007-10-24 Peptcell Ltd Peptide sequences and compositions

Also Published As

Publication number Publication date
WO2011086535A1 (en) 2011-07-21
FR2955393A1 (en) 2011-07-22
AP2012006415A0 (en) 2012-08-31
EP2526418A1 (en) 2012-11-28

Similar Documents

Publication Publication Date Title
EP2619184A4 (en) Deubiquitinase inhibitors and methods for use of the same
BR112013013663A2 (en) substituted 1-benzylcycloalkylcarboxylic acids and their use
EP2649099A4 (en) Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
PT2576758T (en) Continuous or semi-continuous flow photobioreactor and method of use
BR112013009965A2 (en) "system and method"
BR112012028883A2 (en) liquid supply and method
DK2600715T3 (en) Liquid ST-246 formulations and methods
DK2917231T3 (en) Lipopeptides for use in the treatment of liver diseases and cardiovascular diseases
ITTO20110638A1 (en) PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES
DK3173102T3 (en) FGFR-FC fusion protein and its use
ITTO20110640A1 (en) PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH THE CARDIOVASCULAR SYSTEM
BRPI1008159A2 (en) non-ad5 adenoviral vectors and related methods and uses
DK2571812T3 (en) Adsorbents containing titanium and iron compounds
BR112013008447A2 (en) '' Liquid cleaning composition and method ''
FR2956120B1 (en) METHOD OF DIRECT HYDROLIQUEFACTION OF ALGAE IN BEDS
ITUD20110134A1 (en) "WELDING PROCEDURE OF A MATTRESS LINING AND SYSTEM THAT OPERATES THE PROCEDURE"
FR2998894B1 (en) METHOD OF FRACTIONING ALGAE AND USING THE OBTAINED MOLECULES
EP2934501A4 (en) Uses and methods for the treatment of liver diseases or conditions
ZA201201810B (en) Maleic acid salt and crystal thereof
DK2709638T3 (en) Composition with honey and L-alanyl-L-glutamine
FR2955393B1 (en) METHOD FOR ASSESSING THE EFFECTIVENESS OF VECTOR CONTROL STRATEGIES IN THE CONTROL OF MALARIA AND ARBOVIROSIS
BR112012022018A2 (en) '' connecting bridge ''
FR2973050B3 (en) SOIL COMPOSITION FOR IMPROVING HIPPICAL SURFACES
EP2758530A4 (en) Shigella-derived vector and methods of using the same
GB201122146D0 (en) Screening methods to identify compounds useful in the prevention and/or treatment of inflammatory conditions

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15